Therefore, prior to the design and implementation of effective tumor therapy, it is of great significance to deeply explore the pathological mechanism of HIF-1α expression and develop targeted therapies for it to improve the therapeutic effect and overcome drug resistance. This evidence concerns the gene HIF1A and neoplasm.